Document Detail


Diabetic retinopathy: pathogenesis, clinical grading, management and future developments.
MedLine Citation:
PMID:  23205608     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Decades of research into the pathophysiology and management of diabetic retinopathy have revolutionized our understanding of the disease process. Diabetic retinopathy is now more accurately defined as a neurovascular rather than a microvascular disease as neurodegenerative disease precedes and coexists with microvascular changes. However, the complexities of the pathways involved in different stages of disease severity continue to remain a challenging issue for drug discovery. Currently, laser photocoagulation is the mainstay of treatment for proliferative diabetic retinopathy, but is gradually being superseded for diabetic macular oedema. However, it is destructive and at best results in a gradual but modest improvement in vision in the long term. So, diabetic retinopathy remains the most prevalent cause of visual impairment in the working-age population despite established screening programmes, early diagnosis and treatment of the condition. The recent discovery of inhibitors of vascular endothelial growth factors is revolutionizing the management of diabetic retinopathy, particularly diabetic macular oedema. However, not all patients respond to anti-vascular endothelial growth factors agents, reinforcing the fact that diabetic retinopathy is a multifactorial disease. Studies are still required to improve our understanding of how retinal structure correlates with visual function. It is hoped that these will lead to better characterization of the disease phenotype based on treatment responses to different agents and allow an algorithm to be developed that will guide the management of diabetic retinopathy and diabetic macular oedema at different stages of severity. © 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
Authors:
L Z Heng; O Comyn; T Peto; C Tadros; E Ng; S Sivaprasad; P Hykin
Related Documents :
23172268 - Changes to medication-use processes after overdose of u-500 regular insulin.
23286438 - How should we treat hypertension and dyslipidemia in patients with prediabetes?
23063048 - Diabetic autonomic imbalance and glycemic variability.
11441418 - Viral reduction techniques: types and purpose.
9618928 - Urine arsenic concentrations in healthy adults as indicators of environmental contamina...
14657618 - Prevalence of metabolic syndrome among hypertensive patients attending a primary care c...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-4
Journal Detail:
Title:  Diabetic medicine : a journal of the British Diabetic Association     Volume:  -     ISSN:  1464-5491     ISO Abbreviation:  Diabet. Med.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8500858     Medline TA:  Diabet Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
Affiliation:
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  FGF19 (fibroblast growth factor 19) as a novel target gene for activating transcription factor 4 in ...
Next Document:  Abiotic oxidation of Fe(II) by reactive nitrogen species in cultures of the nitrate-reducing Fe(II) ...